Key result
Survivors of hematopoietic stem cell transplantation remain at risk for cardiovascular disease at a rate at least fourfold higher than the general population, warranting aggressive screening.
Population
Patients undergoing or surviving hematopoietic stem cell transplantation (HSCT)
Design
Review
Authors
Loading...
May warrant pretransplant cardiac screening in HSCT survivors; leaves open prospective validation of protocols.
HSCT survivors have a significantly elevated risk of cardiovascular complications, warranting aggressive screening and management of cardiac risk factors in collaboration with cardio-oncology.
Blaes et al. (2016) conducted a review in Hematopoietic Stem Cell Transplantation. Hematopoietic Stem Cell Transplantation was evaluated. Survivors of hematopoietic stem cell transplantation remain at risk for cardiovascular disease at a rate at least fourfold higher than the general population, warranting aggressive screening.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: